Ontology type: schema:ScholarlyArticle Open Access: True
2018-11-01
AUTHORSTomoko Horinouchi, Mayumi Sako, Koichi Nakanishi, Kenji Ishikura, Shuichi Ito, Hidefumi Nakamura, Mari Saito Oba, Kandai Nozu, Kazumoto Iijima
ABSTRACTBackgroundIdiopathic nephrotic syndrome (INS) is the most common chronic glomerular disease in children. Approximately 80–90% of patients with childhood INS have steroid-sensitive nephrotic syndrome (SSNS), and can obtain remission with steroid therapy, while the remainder have steroid-resistant nephrotic syndrome (SRNS). Furthermore, approximately 50% of children with SSNS develop frequently-relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS). Children with FRNS/SDNS are usually treated with immunosuppressive agents such as cyclosporine, cyclophosphamide, or mizoribine in Japan. However, 10–20% of children receiving immunosuppressive agents still show frequent relapse and/or steroid dependence during or after treatment, which is defined as complicated FRNS/SDNS. Furthermore, 30% of SRNS patients who obtain remission after additional treatments such as cyclosporine also turn out to be complicated FRNS/SDNS. For such complicated FRNS/SDNS patients, rituximab (RTX) is currently used; however, recurrence after RTX treatment also remains an open issue. Because long-term use of existing immunosuppressive drugs has limitations, development of a novel treatment for maintenance therapy after RTX is desirable. Mycophenolate mofetil (MMF) is an immunosuppressive drug with fewer side effects than cyclosporine or cyclophosphamide. Importantly, recent studies have reported the efficacy of MMF in children with nephrotic syndrome.MethodsWe conduct a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of MMF after RTX therapy in children with complicated FRNS/SDNS. Patients are allocated to either RTX plus MMF treatment group, or RTX plus placebo treatment group. For the former group, MMF is administered at a dose of 1000–1200 mg/m2/day (maximum 2 g/day) twice daily for 17 months after RTX treatment. The primary endpoint is time-to-treatment failure (development of frequent relapses, steroid dependence or steroid resistance).DiscussionThe results will provide important data on the use of MMF as maintenance therapy after RTX to prevent complicated FRNS/SDNS patients from declining into treatment failure. In future, MMF in conjunction with RTX treatment may permit increased duration of remission in ‘complicated’ FRNS/SDNS cases.Trial registrationThis trial was prospectively registered to UMIN Clinical Trials Registry on June 23, 2014 (UMIN Trial ID: UMIN000014347). More... »
PAGES302
http://scigraph.springernature.com/pub.10.1186/s12882-018-1099-7
DOIhttp://dx.doi.org/10.1186/s12882-018-1099-7
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1107953414
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30382824
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Child",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Double-Blind Method",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Therapy, Combination",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunologic Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mycophenolic Acid",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Nephrotic Syndrome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Recurrence",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rituximab",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Steroids",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Pediatrics, Kobe University Graduate School of Medicine, 5-1 Kusunoki-cho 7 chome, Chuo-ku, 650-0017, Kobe, Japan",
"id": "http://www.grid.ac/institutes/grid.31432.37",
"name": [
"Department of Pediatrics, Kobe University Graduate School of Medicine, 5-1 Kusunoki-cho 7 chome, Chuo-ku, 650-0017, Kobe, Japan"
],
"type": "Organization"
},
"familyName": "Horinouchi",
"givenName": "Tomoko",
"id": "sg:person.013371647075.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013371647075.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division for Clinical Trials, Department of Clinical Research Promotion, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.63906.3a",
"name": [
"Division for Clinical Trials, Department of Clinical Research Promotion, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Sako",
"givenName": "Mayumi",
"id": "sg:person.01032464245.22",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032464245.22"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan",
"id": "http://www.grid.ac/institutes/grid.267625.2",
"name": [
"Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan"
],
"type": "Organization"
},
"familyName": "Nakanishi",
"givenName": "Koichi",
"id": "sg:person.0611445101.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611445101.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.63906.3a",
"name": [
"Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Ishikura",
"givenName": "Kenji",
"id": "sg:person.01112735663.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112735663.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Ito",
"givenName": "Shuichi",
"id": "sg:person.012302533312.63",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.63906.3a",
"name": [
"Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Nakamura",
"givenName": "Hidefumi",
"id": "sg:person.016521443562.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016521443562.02"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medical Statistics, Toho University, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.265050.4",
"name": [
"Department of Medical Statistics, Toho University, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Oba",
"givenName": "Mari Saito",
"id": "sg:person.0755444204.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755444204.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Kobe University Graduate School of Medicine, 5-1 Kusunoki-cho 7 chome, Chuo-ku, 650-0017, Kobe, Japan",
"id": "http://www.grid.ac/institutes/grid.31432.37",
"name": [
"Department of Pediatrics, Kobe University Graduate School of Medicine, 5-1 Kusunoki-cho 7 chome, Chuo-ku, 650-0017, Kobe, Japan"
],
"type": "Organization"
},
"familyName": "Nozu",
"givenName": "Kandai",
"id": "sg:person.0717317506.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717317506.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Kobe University Graduate School of Medicine, 5-1 Kusunoki-cho 7 chome, Chuo-ku, 650-0017, Kobe, Japan",
"id": "http://www.grid.ac/institutes/grid.31432.37",
"name": [
"Department of Pediatrics, Kobe University Graduate School of Medicine, 5-1 Kusunoki-cho 7 chome, Chuo-ku, 650-0017, Kobe, Japan"
],
"type": "Organization"
},
"familyName": "Iijima",
"givenName": "Kazumoto",
"id": "sg:person.01360637141.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360637141.54"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00467-006-0060-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039372955",
"https://doi.org/10.1007/s00467-006-0060-3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-011-1886-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038755333",
"https://doi.org/10.1007/s00467-011-1886-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-003-1300-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032638307",
"https://doi.org/10.1007/s00467-003-1300-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-006-0294-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001089825",
"https://doi.org/10.1007/s00467-006-0294-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-008-0814-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047664910",
"https://doi.org/10.1007/s00467-008-0814-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-012-2393-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020767792",
"https://doi.org/10.1007/s00467-012-2393-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-004-1778-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039990387",
"https://doi.org/10.1007/s00467-004-1778-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-011-1894-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032375811",
"https://doi.org/10.1007/s00467-011-1894-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-003-1175-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010530284",
"https://doi.org/10.1007/s00467-003-1175-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10157-016-1319-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022803771",
"https://doi.org/10.1007/s10157-016-1319-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-004-1434-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034927167",
"https://doi.org/10.1007/s00467-004-1434-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-009-1377-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022984402",
"https://doi.org/10.1007/s00467-009-1377-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-005-1877-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025163770",
"https://doi.org/10.1007/s00467-005-1877-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10157-014-1030-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019458362",
"https://doi.org/10.1007/s10157-014-1030-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-009-1191-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052697168",
"https://doi.org/10.1007/s00467-009-1191-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10157-016-1313-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036768788",
"https://doi.org/10.1007/s10157-016-1313-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-007-0617-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004619628",
"https://doi.org/10.1007/s00467-007-0617-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s004670050558",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045165754",
"https://doi.org/10.1007/s004670050558"
],
"type": "CreativeWork"
}
],
"datePublished": "2018-11-01",
"datePublishedReg": "2018-11-01",
"description": "BackgroundIdiopathic nephrotic syndrome (INS) is the most common chronic glomerular disease in children. Approximately 80\u201390% of patients with childhood INS have steroid-sensitive nephrotic syndrome (SSNS), and can obtain remission with steroid therapy, while the remainder have steroid-resistant nephrotic syndrome (SRNS). Furthermore, approximately 50% of children with SSNS develop frequently-relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS). Children with FRNS/SDNS are usually treated with immunosuppressive agents such as cyclosporine, cyclophosphamide, or mizoribine in Japan. However, 10\u201320% of children receiving immunosuppressive agents still show frequent relapse and/or steroid dependence during or after treatment, which is defined as complicated FRNS/SDNS. Furthermore, 30% of SRNS patients who obtain remission after additional treatments such as cyclosporine also turn out to be complicated FRNS/SDNS. For such complicated FRNS/SDNS patients, rituximab (RTX) is currently used; however, recurrence after RTX treatment also remains an open issue. Because long-term use of existing immunosuppressive drugs has limitations, development of a novel treatment for maintenance therapy after RTX is desirable. Mycophenolate mofetil (MMF) is an immunosuppressive drug with fewer side effects than cyclosporine or cyclophosphamide. Importantly, recent studies have reported the efficacy of MMF in children with nephrotic syndrome.MethodsWe conduct a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of MMF after RTX therapy in children with complicated FRNS/SDNS. Patients are allocated to either RTX plus MMF treatment group, or RTX plus placebo treatment group. For the former group, MMF is administered at a dose of 1000\u20131200\u00a0mg/m2/day (maximum 2\u00a0g/day) twice daily for 17\u00a0months after RTX treatment. The primary endpoint is time-to-treatment failure (development of frequent relapses, steroid dependence or steroid resistance).DiscussionThe results will provide important data on the use of MMF as maintenance therapy after RTX to prevent complicated FRNS/SDNS patients from declining into treatment failure. In future, MMF in conjunction with RTX treatment may permit increased duration of remission in \u2018complicated\u2019 FRNS/SDNS cases.Trial registrationThis trial was prospectively registered to UMIN Clinical Trials Registry on June 23, 2014 (UMIN Trial ID: UMIN000014347).",
"genre": "article",
"id": "sg:pub.10.1186/s12882-018-1099-7",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.7853213",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1024626",
"issn": [
"1471-2369"
],
"name": "BMC Nephrology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "19"
}
],
"keywords": [
"steroid-dependent nephrotic syndrome",
"steroid-sensitive nephrotic syndrome",
"steroid-resistant nephrotic syndrome",
"placebo-controlled trial",
"FRNS/",
"mycophenolate mofetil",
"nephrotic syndrome",
"maintenance therapy",
"RTX treatment",
"immunosuppressive agents",
"treatment failure",
"immunosuppressive drugs",
"treatment groups",
"common chronic glomerular disease",
"efficacy of MMF",
"safety of MMF",
"use of MMF",
"UMIN Clinical Trials Registry",
"BackgroundIdiopathic nephrotic syndrome",
"MMF treatment group",
"placebo treatment groups",
"duration of remission",
"Clinical Trials Registry",
"chronic glomerular disease",
"long-term use",
"steroid therapy",
"primary endpoint",
"rituximab treatment",
"frequent relapses",
"RTX therapy",
"SRNS patients",
"Trials Registry",
"steroid dependence",
"glomerular disease",
"side effects",
"novel treatments",
"patients",
"syndrome",
"therapy",
"remission",
"cyclosporine",
"m2/day",
"RTX",
"additional treatment",
"trials",
"former group",
"mofetil",
"multicenter",
"cyclophosphamide",
"treatment",
"children",
"drugs",
"efficacy",
"Recent studies",
"group",
"mizoribine",
"relapse",
"recurrence",
"failure",
"registry",
"agents",
"MethodsWe",
"disease",
"dose",
"endpoint",
"months",
"duration",
"days",
"safety",
"important data",
"use",
"remainder",
"cases",
"study",
"effect",
"data",
"development",
"time",
"Japan",
"conjunction",
"results",
"limitations",
"INS",
"future",
"issues",
"dependence",
"open issues"
],
"name": "Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)",
"pagination": "302",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1107953414"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s12882-018-1099-7"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30382824"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s12882-018-1099-7",
"https://app.dimensions.ai/details/publication/pub.1107953414"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:21",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_783.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s12882-018-1099-7"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12882-018-1099-7'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12882-018-1099-7'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12882-018-1099-7'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12882-018-1099-7'
This table displays all metadata directly associated to this object as RDF triples.
338 TRIPLES
22 PREDICATES
142 URIs
116 LITERALS
18 BLANK NODES